Literature DB >> 27326219

Prevalence of rheumatic heart disease in Senegalese school children: a clinical and echocardiographic screening.

Aliou Alassane Ngaïdé1, Alassane Mbaye1, Adama Kane2, Mouhamadou Bamba Ndiaye3, Modou Jobe4, Malick Bodian3, Momar Dioum3, Simon Antoine Sarr3, Fatou Aw3, Prisca Sede Mbakop1, Fatimata Gatta Ba3, Ngoné Diaba Gaye1, Alioune Tabane3, Mamadou Bassirou Bah3, Sarah Mouna Coly3, Dior Diagne1, Bouna Diack1, Maboury Diao3, Abdoul Kane1.   

Abstract

OBJECTIVE: To study the prevalence of rheumatic heart disease (RHD) in schools (locally referred to as 'daaras') located in the city of Dakar and its suburbs using both clinical examination and echocardiography.
METHODS: This is a cross-sectional study conducted from 9 August to 24 December 2011 involving 2019 pupils, aged between 5 and 18 years selected from the 16 'daaras' of the Academic Inspectorate (Inspection d'Académie) of the city of Dakar and its suburbs. Anamnestic, clinical and echocardiographic data were collected and entered into a questionnaire designed for the study. The World Heart Federation criteria for echocardiographic diagnosis were used to diagnose RHD. p<0.05 was considered statistically significant in bivariate analysis.
RESULTS: About 60.1% of the pupils were men and the mean age was 9.7±3.3 years. 10 cases of definite RHD were detected, prevalence being 4.96 per 1000 (95% CI 2.4 to 9.1). This prevalence was five times higher with echocardiographic screening compared with clinical screening. 23 cases (11.4 per 1000) of borderline forms were detected. The populations at risk of definite RHD identified in our study were children over 14 years (p<0.001), those with recurrent sore throat (p=0.003) and those residing in the suburbs of the city of Dakar (p<0.001).
CONCLUSION: Our study shows a relatively high prevalence of RHD. Reducing its prevalence should focus on the implementation of appropriate policies, targeting at-risk populations and focusing on raising awareness and early detection.

Entities:  

Keywords:  VALVULAR DISEASE

Year:  2015        PMID: 27326219      PMCID: PMC4832814          DOI: 10.1136/heartasia-2015-010664

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  20 in total

Review 1.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

2.  Echocardiographic screening for rheumatic heart disease.

Authors:  Eloi Marijon; Phalla Ou; David S Celermajer; Beatriz Ferreira; Ana Olga Mocumbi; Daniel Sidi; Xavier Jouven
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 3.  Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.

Authors:  Liesl Zühlke; Bongani M Mayosi
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

4.  Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1988

5.  Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania.

Authors:  Regan Bergmark; Brian Bergmark; Jeffrey Blander; Maulidi Fataki; Mohamed Janabi
Journal:  Pediatr Infect Dis J       Date:  2010-12       Impact factor: 2.129

6.  Prevalence of rheumatic heart disease in school children of urban Lahore.

Authors:  M Sadiq; K Islam; R Abid; F Latif; A U Rehman; A Waheed; M Azhar; J S Khan
Journal:  Heart       Date:  2008-10-24       Impact factor: 5.994

Review 7.  Epidemiology of heart failure in sub-Saharan Africa.

Authors:  Ntobeko B A Ntusi; Bongani M Mayosi
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-02

8.  The return of acute rheumatic fever in young adults.

Authors:  M R Wallace; P D Garst; T J Papadimos; E C Oldfield
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

9.  Occurrence, aetiology and challenges in the management of congestive heart failure in sub-Saharan Africa: experience of the Cardiac Centre in Shisong, Cameroon.

Authors:  Jacques Cabral Tantchou Tchoumi; Jean Claude Ambassa; Samuel Kingue; Alessandro Giamberti; Sylvia Cirri; Alessandro Frigiola; Gianfranco Butera
Journal:  Pan Afr Med J       Date:  2011-02-17

Review 10.  The challenges of cardiac surgery for African children.

Authors:  Ana O H Mocumbi
Journal:  Cardiovasc J Afr       Date:  2012-04       Impact factor: 1.167

View more
  9 in total

1.  Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease.

Authors:  Ekanem N Ekure; Casmir Amadi; Ogochukwu Sokunbi; Nnenna Kalu; Akinsanya Olusegun-Joseph; Oyewole Kushimo; Olayinka Hassan; Desmond Ikebudu; Sophia Onyia; Chinonso Onwudiwe; Victor Nwankwo; Remi Akinwunmi; Fukpode Awusa; Zainab Akere; Olaolu Dele-Salawu; Elizabeth Ajayi; Olagoke Ale; Dorothy Muoneke; Maximillian Muenke; Paul Kruszka; Andrea Beaton; Craig Sable; Adebowale Adeyemo
Journal:  Trop Med Int Health       Date:  2019-04-08       Impact factor: 2.622

2.  Prevalence of rheumatic heart disease among school children in East Africa: a systematic review and meta-analysis.

Authors:  Melaku Bimerew; Biruk Beletew; Addisu Getie; Adam Wondmieneh; Getnet Gedefaw; Asmamaw Demis
Journal:  Pan Afr Med J       Date:  2021-03-08

3.  Epidemiology of pharyngitis as reported by Zambian school children and their families: implications for demand-side interventions to prevent rheumatic heart disease.

Authors:  John Musuku; Joyce C Lungu; Elizabeth Machila; Catherine Jones; Laurence Colin; Sherri Schwaninger; Patrick Musonda; Brigitta Tadmor; Jonathan M Spector; Mark E Engel; Liesl J Zühlke
Journal:  BMC Infect Dis       Date:  2017-07-06       Impact factor: 3.090

4.  Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies.

Authors:  Jean Jacques Noubiap; Valirie N Agbor; Jean Joel Bigna; Arnaud D Kaze; Ulrich Flore Nyaga; Bongani M Mayosi
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

5.  Prevalence and risk factors for Subclinical Rheumatic Heart Disease among primary school children in Dar es Salaam, Tanzania: a community based cross-sectional study.

Authors:  Parvina Titus Kazahura; Theophylly L Mushi; Pedro Pallangyo; Mohamed Janabi; Rodrick Kisenge; Mazen Albaghdadi; Naizihijwa Majani; Edward Kija
Journal:  BMC Cardiovasc Disord       Date:  2021-12-20       Impact factor: 2.298

6.  Screening for subclinical rheumatic heart disease: addressing borderline disease in a real-world setting.

Authors:  Luke D Hunter; Alfonso J K Pecoraro; Anton F Doubell; Mark J Monaghan; Guy W Lloyd; Carl J Lombard; Philip G Herbst
Journal:  Eur Heart J Open       Date:  2021-12-27

Review 7.  Screening for rheumatic heart disease: is a paradigm shift required?

Authors:  L D Hunter; M Monaghan; G Lloyd; A J K Pecoraro; A F Doubell; P G Herbst
Journal:  Echo Res Pract       Date:  2017-09-01

8.  Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting.

Authors:  Clovis Nkoke; Engelbert Bain Luchuo; Ahmadou Musa Jingi; Christelle Makoge; Ba Hamadou; Anastase Dzudie
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

9.  Prevalence of rheumatic heart disease in Zambian school children.

Authors:  John Musuku; Mark E Engel; Patrick Musonda; Joyce Chipili Lungu; Elizabeth Machila; Sherri Schwaninger; Agnes Mtaja; Evans Mulendele; Dorothy Kavindele; Jonathan Spector; Brigitta Tadmor; Marcelo M Gutierrez; Joris Van Dam; Laurence Colin; Aidan Long; Mark C Fishman; Bongani M Mayosi; Liesl J Zühlke
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.